Clinical Trial Update: Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain® [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the inflammatory and healing response after root coverage with Emdogain in gingival recession and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)

Snippet

Sponsor: Rio de Janeiro State University | Conditions: Gingival Recession | Phase 4 | Status: COMPLETED